BURLINGTON, Mass. and JERUSALEM, May 04, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the Company will be presenting real world results for Deep TMS™ in the treatment of major depressive disorder at the upcoming Clinical TMS Society Annual Meeting in Chicago. The Annual Meeting of the Clinical TMS Society provides a forum to connect with TMS providers and researchers from around the world.